RAPT Therapeutics Inc (RAPT) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $57.96
• Market Cap: $1.68B
• EPS: $-11.66
• 52-Week High: $57.98
• 52-Week Low: $5.66

Market Sentiment

RAPT Therapeutics Inc currently has a Bullish sentiment score of 0.26.

About RAPT Therapeutics Inc

RAPT Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in South San Francisco, California, focused on revolutionizing treatments for oncology and inflammatory diseases with its oral small molecule therapies. Leveraging a proprietary drug discovery platform that targets key immune regulatory pathways, RAPT is advancing a promising pipeline aimed at addressing critical unmet medical needs. The company is strategically positioned to deliver novel therapeutic options through ...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for RAPT Therapeutics Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does RAPT pay dividends?

RAPT Therapeutics Inc (RAPT) does not currently pay a regular dividend.

What is RAPT's market cap?

RAPT Therapeutics Inc (RAPT) has a market capitalization of $1.68B with a current stock price of $57.96.